Diabetes and COVID-19 | ACROSS T2D

Diabetes and COVID-19

This module summarises recent guidance for healthcare professionals to provide optimal care of their patients with T2D during the COVID-19 pandemic

Diabetes and COVID-19

Diabetes and COVID-19
Contents
Login or create an account to see restricted content
People with diabetes and/or related comorbidities are at higher risk of severe illness from COVID-19, particularly if conditions are not well controlled
Login or create an account to see restricted content
COVID-19-related mortality rates are higher in patients with diabetes, CV disease or hypertension compared with the general population
Login or create an account to see restricted content
Higher risk of COVID-19-related hospital death for patients with uncontrolled diabetes, obesity, heart or kidney disease
Login or create an account to see restricted content
Poor glycaemic control is associated with lower survival rates among hospitalised patients with T2D and COVID-19
Login or create an account to see restricted content
Patients with diabetes and/or other comorbidities have an increased risk of worse outcomes with COVID-19 infection
Login or create an account to see restricted content
Pathophysiology of COVID-19
Login or create an account to see restricted content
Potential reasons for patients with diabetes having increased risk of severe COVID-19 infection
Login or create an account to see restricted content
Contents
Login or create an account to see restricted content
Good glycaemic control may help reduce the risk and severity of COVID-19 infection
Login or create an account to see restricted content
CV risk factor and lifestyle management are important factors that should not be forgotten during the COVID-19 outbreak
Login or create an account to see restricted content
There is currently no supporting evidence for patients to interrupt their prescribed NSAIDs treatment during the COVID-19 outbreak
Login or create an account to see restricted content
Professional societies strongly encourage patients to continue taking ACEis/ARBs for hypertension
Login or create an account to see restricted content
Evidence shows no association between ACEi/ARB treatment and COVID-19 test positivity
Login or create an account to see restricted content
Patients may be worried about their condition during the COVID-19 outbreak; it is important to provide reassurance
Login or create an account to see restricted content
Continue to optimise care of patients with diabetes during the COVID-19 outbreak
Login or create an account to see restricted content
Remote visits allow clinicians to provide best clinical care whilst maintaining social distancing
Login or create an account to see restricted content
Considerations for remote visits
Login or create an account to see restricted content
Conducting video visits
Login or create an account to see restricted content
Delay in testing of biochemical parameters due to COVID-19: what is appropriate?
Login or create an account to see restricted content
Everyone, especially people at increased risk of complications, should follow general preventative measures during the COVID-19 outbreak
Login or create an account to see restricted content
Contents
Login or create an account to see restricted content
What should be done if a patient with diabetes in your care has COVID-19 with mild-to-moderate symptoms?
Login or create an account to see restricted content
In periods of acute illness, all patients should follow sick-day rules to minimise risk of complications (1)
Login or create an account to see restricted content
In periods of acute illness, all patients should follow sick-day rules to minimise risk of complications (2)
Login or create an account to see restricted content
In periods of acute illness, all patients should follow sick‑day rules to minimise risk of complications (3)
Login or create an account to see restricted content
Considerations for glucose-lowering therapies in patients with suspected or COVID-19-positive patients with T2D
Login or create an account to see restricted content
Considerations for a patient with diabetes if hospitalised with COVID-19 symptoms
Login or create an account to see restricted content
Strategy for management of patients with diabetes hospitalised with COVID-19 infection based on cardiometabolic status and CV risk factors
Login or create an account to see restricted content
Key considerations